Biogerontechnology can help extend the human lifespan as well as help retain or restore physical independence and mental capacity in the old age.
This technology also deals with tissue regeneration, which may help fight diseases like cancer and diabetes as well as potentially generate new organs and tissues by means off stem cell technology.
This technology may help older adults be independent in both physical and mental capacity, and live more fulfilling lives even at the old age.
This technology has a lot of promise for the betterment of the lives of aging population and it may help avert debilitating and disabling diseases. It may also help those less fortunate with organ replacements, and it may help improve prosthetic limb technology for amputees and returning war veterans who were injured in combat.
As far as making prediction for the potential use of this technology, it is hard to say how many people will actually be able to benefit from this technology, and how soon.
It is also hard to predict how much controversy this technology may raise with the opponents of the stem cell research technology that will go into tissue regeneration.
Although there is an expectation of reduced health-care costs as the benefit of this technology, it is hard to predict the general availability of this technology because of the potentially nationalized Health-care System (Obama Care) that may dictate the availability rules, and potential governmental restrictions put on the use of Biogerontechnology.
Of course, it would be great if this technology became financially viable and available for the benefit of general population at least in the U.S. This way people would be able to remain productive for a longer period of time. They could further invest their acquired knowledge and experience to contribute towards betterment of society.
It would also make elder care more competitive, because of a potentially decreased demand, thereby raising the actual quality of care through increased competition on the supply side.
At this point it is very difficult to predict the progress of Biogerontechnology in terms of scientific research and its results, funding, governmental and societal embrace, and implementation and commercialization.